# clm_C02D22EACC34

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: cash_and_equivalents  
value: 7,998,200,000 United States dollar  
valid_from: 2018-12-31  
valid_to: 2019-03-31  
published: 2019-02-19  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_30B8DAA128A6  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company cash and equivalents: 7,998,200,000 United States dollar", as of 2018-12-31 (until 2019-03-31). Claim clm_C02D22EACC34, https://asof.is/claim/clm_C02D22EACC34, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947819000082/0000059478-19-000082-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-19  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947819000082/0000059478-19-000082-index.htm (primary, SEC EDGAR 10-K FY2018, published 2019-02-19)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | cash_and_equivalents | 8,960,000,000 United States dollar | valid 2018-09-30 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_C02D22EACC34](/claim/clm_C02D22EACC34.md) | [clm_C653C5087E4A](/claim/clm_C653C5087E4A.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.